More Immutep Ltd news
Immutep LtdASX: IMM

S&P DJI Announces September 2024 Quarterly Rebalance

Sep 6, 2024 at 7:31 AM EDT · Issued by Immutep Ltd

Filed with ASX · Sep 6, 2024 at 7:31 AM EDT · 4 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-september-2024-quarterly-rebalance-6

Immutep Ltd on 6ix

Earlier from Immutep

  • Appendix 4E & 2024 Full Year Statutory AccountsAug 30, 2024
  • TACTI-003 data selected for oral presentation at ESMO 2024Aug 20, 2024
  • First Participant Dosed in Phase I Study of IMP761Aug 13, 2024
  • Successful Meeting with FDA on Phase III Design in NSCLCJul 21, 2024
  • Regulatory Clearance received for Phase 1 trial of IMP761Jul 16, 2024

Later from Immutep

  • New Positive Efficacy Data for Efti in Head and Neck CancerSep 15, 2024
  • Immutep receives A$3.6 million French R&D Tax IncentiveSep 23, 2024
  • Enrolment for Ph II AIPAC-003 Breast Cancer Trial CompletedOct 3, 2024
  • Positive Data from Phase II Trial in Soft Tissue SarcomaNov 13, 2024
  • Excellent Survival Data from INSIGHT-003 Trial in NSCLCNov 13, 2024
All Immutep news releases↗

Follow Immutep into a list and get an email when it puts out news.

Follow Immutep
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer